Menopause Does Not Reduce Hematoma Risk After Reduction Mammoplasty Surgery: A Retrospective Analysis

Abstract

Objective: Hematoma is one of the early complications of breast reduction surgery. According to our literature review, this concomitance was not discussed in detail. The aim of this study is to show the relationship of postoperative hematoma with menopausal status in reduction mammoplasty patients.

Methods: This study included 153 patients who underwent breast reduction surgery from 2014 to 2018, and had no comorbid disease and were questioned for menopause retrospectively. The patients were divided into two groups: Group 1 comprised premenopausal women, and Group 2 comprised postmenopausal women.

Results: The mean age of the patients in Group 1 and Group 2 was 33.26 +/- 7.58 years and 52.96 +/- 4.34 years, respectively (p=0.00). The mean of total resected tissue weights in Groups 1 and 2 were 2.104 +/- 1.201 grammes and 2.492 +/- 1.098 grammes, respectively (p=0.119). Hematomas were seen in six (4.8%) patients in Group 1, and no hematoma was seen in Group 2 (p=0.593).

Conclusion: Our findings showed that menopause does not reduce the risk for hematoma, but we recommend further clinical studies.